1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Germany Pharmaceuticals and Healthcare Report Q4 2016

Germany Pharmaceuticals and Healthcare Report Q4 2016

  • September 2016
  • -
  • Business Monitor International
  • -
  • 102 pages

Includes 3 FREE quarterly updates


BMI View: Germany's large and expanding pharmaceutical market will continue to generate commercial opportunities for drugmakers over the forecast period. While Germany's ongoing economic rebalancing will continue to support robust domestic consumption indices, including in health sector segments, healthcare spending will also be driven by population growth owing to net migration in the medium term. Meanwhile, German economic resilience after the UK's EU referendum vote bodes well for the country's healthcare and pharmaceuticals growth story. However, heightened economic and political risks will remain a key concern for Germany, posing downside risks to our sector forecasts.

Headline Expenditure Projections
- Pharmaceuticals: EUR46.50bn (USD50.62bn) in 2015 to EUR46.98bn (USD51.68bn) in 2016; +1.0% in local currency terms and 2.1% in US dollar terms. Forecast revised downwards in local currency terms and upwards in US dollar terms from last quarter.
- Healthcare: EUR339.63bn (USD369.76bn) in 2015 to EUR350.32bn (USD385.35bn) in 2016; +3.2% in local currency terms and +4.2% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Germany Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Germany 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Germany 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 19
Table: Retail Pharmaceutical Expenditure, 2003-2010 (EURbn) 19
Table: Retail Pharmaceutical Expenditure, 2003-2010 (Packages, ms) 20
Table: Retail Pharmaceutical Expenditure, 2003-2010 (Average Price per Pack, EUR) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 23
Generic Medicine Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 26
OTC Medicines Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Germany 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Germany 2014-2020) 31
Pharmaceuticals Risk/Reward Index 32
Western Europe Risk/Reward Index 32
Germany Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Intellectual Property Regime 42
Pricing Regime 43
Reimbursement Regime 46
Market Overview 48
Healthcare Sector 49
Table: Healthcare Resources (Germany 2010-2015) 51
Table: Healthcare Personnel (Germany 2010-2015) 52
Table: Healthcare Activity (Germany 2010-2015) 52
Research and Development 52
Clinical Trials 58
Epidemiology 59
Competitive Landscape 62
Research-Based Industry 62
Table: Multinational Market Activity 64
Pharmaceutical Distribution 65
Pharmaceutical Retail Sector 65
Company Profile 67
Bayer Health Care 67
Boehringer Ingelheim 72
GlaxoSmithKline (GSK) 77
Merck KGaA 80
Pfizer 84
STADA Arzneimittel 87
Demographic Forecast 91
Demographic Outlook 91
Table: Population Headline Indicators (Germany 1990-2025) 92
Table: Key Population Ratios (Germany 1990-2025) 92
Table: Urban/Rural Population and Life Expectancy (Germany 1990-2025) 93
Table: Population By Age Group (Germany 1990-2025) 93
Table: Population By Age Group % (Germany 1990-2025) 94
Glossary 96
Methodology 98
Pharmaceutical Expenditure Forecast Model 98
Healthcare Expenditure Forecast Model 98
Notes On Methodology 99
Risk/Reward Index Methodology 100
Index Overview 101
Table: Pharmaceutical Risk/Reward Index Indicators 101
Indicator Weightings 102

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.